“…Excitatory cells predominantly expressed various GABAergic and serotonergic receptor classes and primarily expressed some dopaminergic (DRD3) and cholinergic (CHRM5) receptors, with RA-specific Excit_1 primarily expressing GABRE, whereas inhibitory cells primarily expressed other GABAergic subunits, with Inhib_2 primarily expressing GABRG1, CHRM2, and DRD2 ( Figure S7A ). These findings indicate different synaptic specializations of various cell types and provide a cellular basis for the differential expression of various neuromodulatory receptors in RA, 20 , 77 – 80 insights into likely cellular target of action of related drugs known to affect RA physiology, 48 , 78 , 81 – 84 and predictions for cell type-specific effects for future pharmacological studies. As for axonal guidance and connectivity, several genes were differential in excitatory (e.g., ADCYAP1, SEMA3F, CDH17, DCN) vs. inhibitory (e.g., SLIT2, RELN, SEMA3A/C/E, UNC5C) cells ( Figure S7B ).…”